Selling dietary supplements in the EU requires compliance with a specific regulatory framework that treats these products as foodstuffs rather than medicines. Understanding EU food supplement regulations is essential before placing products on the European market.
EU food supplement regulations rest primarily on Directive 2002/46/EC, which defines food supplements as foodstuffs intended to supplement the normal diet and marketed in dose form (capsules, tablets, powders, liquids, etc.). These products must comply with general food law as well as the specific rules of the Food Supplements Directive.
Selling dietary supplements in the EU is not a simple product-category exercise. Composition, labeling, claims, and notification or registration obligations (which can vary by Member State) all interact. In addition, nutrition and health claims are tightly controlled, and certain ingredients may trigger Novel Food rules. Brands that treat supplements as interchangeable with U.S. dietary supplements frequently encounter compliance barriers. A clear understanding of the overall framework is therefore the necessary starting point.
Directive 2002/46/EC restricts the vitamins and minerals that may be used in food supplements to those listed in its Annexes, and only in the chemical forms specifically authorized. Not every vitamin or mineral form accepted in other markets is permitted in the EU.
For substances other than vitamins and minerals (botanicals, other nutrients with physiological effects, etc.), the picture is more complex. Some are subject to national rules or to Regulation (EC) No 1925/2006 on the addition of certain substances to foods. Maximum levels for many vitamins and minerals are still set at national level in the absence of fully harmonized EU maxima, creating additional variation across Member States. Food supplements EU requirements therefore demand careful checking of both the positive lists for vitamins and minerals and any national restrictions that apply to other ingredients.
An ingredient used in a dietary supplement may fall under the Novel Food Regulation (EU) 2015/2283 if it was not used for human consumption to a significant degree within the EU before 15 May 1997. Novel food status can apply to new botanical extracts, new forms of existing substances, engineered nanomaterials, or ingredients with a history of use only outside the EU.
If an ingredient is novel, it generally cannot be placed on the market in food supplements until it has been authorized following a safety assessment. Relying solely on a history of safe use in a third country is not sufficient without following the proper notification or authorization route. Novel food supplements EU issues are a frequent source of compliance problems for brands introducing innovative or non-traditional ingredients. Early assessment of whether any component triggers Novel Food rules is a critical part of EU supplement compliance.
Supplement labeling EU rules combine general food information requirements (Regulation (EU) No 1169/2011) with specific obligations under the Food Supplements Directive. Labels must include the designation “food supplement” (or the equivalent term in the language of the market), the names of the categories of nutrients or substances that characterize the product, the recommended daily portion, a warning not to exceed that dose, a statement that the product should not be used as a substitute for a varied diet, and a warning to keep out of the reach of young children.
For vitamins and minerals, quantities must be declared and expressed as a percentage of the Nutrient Reference Values (NRVs). Ingredient lists, allergen information, and other mandatory particulars under the Food Information to Consumers Regulation also apply. Labels must be in the official language(s) of the Member State where the product is sold. Incomplete, poorly translated, or U.S.-style labels are common reasons for market rejection.
EU health claims supplements are governed by Regulation (EC) No 1924/2006. Only nutrition and health claims that have been authorized and appear in the EU Register may be used, and only under the specific conditions of use (including minimum doses) attached to each claim. Disease-related claims (prevention, treatment, or cure) are prohibited for foods, including food supplements.
Many structure/function-style statements that are common in other markets are not authorized in the EU. Botanical claims remain an area of particular complexity, with a large number of claims still unresolved. Using unauthorized or poorly worded claims is one of the highest-risk compliance areas. Brands must align all on-pack and promotional language with authorized claims and their conditions of use to maintain EU supplement compliance.
Frequent errors include applying U.S.-style claims that have no EU authorization, using vitamin or mineral forms not listed in the EU Annexes, failing to localize labels into the required languages, omitting mandatory warnings, and overlooking Member State-specific notification or maximum-level rules. Another recurring mistake is assuming that a product compliant in one Member State is automatically acceptable across the entire EU without checking national implementations. These oversights often surface only at the point of sale or during official controls, creating costly delays and reformulation needs.
How StrongBody AI + MultiMe Help Supplement Sellers Prepare for EU Compliance
Preparing for EU food supplement regulations requires organized product information, clear mapping of ingredients against permitted lists, careful claims review, and structured documentation. StrongBody AI and MultiMe support sellers by providing a Digital Office environment in which product data, specifications, and compliance-related files can be centralized. This helps teams build a clearer compliance path—identifying which issues require specialist regulatory input and which can be managed internally—before approaching the European market. Structured communication tools further assist in coordinating with partners and advisors during the readiness process.
Once a brand has addressed ingredients, labeling, and claims under EU rules, commercial success still depends on reaching the right customers. StrongBody AI offers a health- and wellness-oriented marketplace environment aligned with the positioning of many food supplements. MultiMe adds global discovery, multilingual communication, structured Requests and Offers, and transaction infrastructure. Together they allow EU-ready brands to convert regulatory readiness into market access without having to construct an entire international sales stack from scratch.
Build EU supplement compliance around permitted ingredients, accurate labeling, and authorized claims. Then turn that readiness into health-market opportunities by connecting with customers through StrongBody AI and MultiMe. Clear regulatory preparation combined with a focused selling ecosystem creates a stronger foundation for selling dietary supplements in the EU.
Read Next
Medical Device Compliance in Germany
